These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1156459

  • 21. Characterization of a polypeptide associated with coated vesicles and the cytoskeleton which is recognized by a CREST serum.
    Bower DJ, Jeppesen P.
    Exp Cell Res; 1986 Nov; 167(1):166-76. PubMed ID: 2875895
    [Abstract] [Full Text] [Related]

  • 22. Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration.
    Furst DE, Clements PJ, Saab M, Sterz MG, Paulus HE.
    Ann Rheum Dis; 1984 Dec; 43(6):794-801. PubMed ID: 6335385
    [Abstract] [Full Text] [Related]

  • 23. Immunofluorescence of HL-A antigens in kidney tissue.
    Sybesma JP, Kater L, Borst-Eilers E, de Planque BA, van Soelen T, Tuit G.
    Proc Eur Dial Transplant Assoc; 1973 Dec; 10(0):406-11. PubMed ID: 4606644
    [No Abstract] [Full Text] [Related]

  • 24. Specific detection of HLA-D antigens using primed LD typing (PLT).
    Sondel PM, Sheehy MJ, Benike C, Alter BJ, Bach FH.
    Transplant Proc; 1976 Sep; 8(3):449-53. PubMed ID: 62435
    [No Abstract] [Full Text] [Related]

  • 25. Histocompatibility typing in amyotrophic lateral sclerosis.
    Antel JP, Arnason BG, Fuller TC, Lehrich JR.
    Arch Neurol; 1976 Jun; 33(6):423-5. PubMed ID: 938267
    [Abstract] [Full Text] [Related]

  • 26. HLA antigens and scleroderma.
    Ercilla MG, Arriaga F, Gratacós MR, Coll J, Lecha V, Vives J, Castillo R.
    Arch Dermatol Res; 1981 Jun; 271(4):381-5. PubMed ID: 6949497
    [No Abstract] [Full Text] [Related]

  • 27. Pulmonary hypertension in the CREST syndrome: variant of systemic sclerosis (scleroderma)--a case report.
    Lie JT.
    Angiology; 1989 Aug; 40(8):764-7. PubMed ID: 2757266
    [Abstract] [Full Text] [Related]

  • 28. [Pathogenetic observations apropos of an association of Crest's syndrome and Gougerot-Sjögren's syndrome].
    Appelboom T, Vandermoeten R, Vandenabeele G.
    Rev Rhum Mal Osteoartic; 1975 Feb; 42(2):127-30. PubMed ID: 1129583
    [No Abstract] [Full Text] [Related]

  • 29. The anticentromere antibody: disease specificity and clinical significance.
    Powell FC, Winkelmann RK, Venencie-Lemarchand F, Spurbeck JL, Schroeter AL.
    Mayo Clin Proc; 1984 Oct; 59(10):700-6. PubMed ID: 6384675
    [Abstract] [Full Text] [Related]

  • 30. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.
    Bernstein RM, Steigerwald JC, Tan EM.
    Clin Exp Immunol; 1982 Apr; 48(1):43-51. PubMed ID: 7044633
    [Abstract] [Full Text] [Related]

  • 31. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H, Rabin BS, Rodnan GP.
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [Abstract] [Full Text] [Related]

  • 32. [Differential diagnosis of Osler's telangiectasia and the CREST syndrome: significance of centromere antibodies].
    Stolz W, Ring J, Meurer M.
    Hautarzt; 1988 Jun; 39(6):371-4. PubMed ID: 3403273
    [Abstract] [Full Text] [Related]

  • 33. [Anticentromere antibodies in rheumatoid polyarthritis with Sjögren syndrome, without the elements of the CREST syndrome].
    Lorcerie B, Tavernier C, Olsson O, Strauss J, Martin F.
    Rev Rhum Mal Osteoartic; 1988 Mar 15; 55(4):291-2. PubMed ID: 3259719
    [No Abstract] [Full Text] [Related]

  • 34. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
    Meurer M, Scharf A, Luderschmidt C, Braun-Falco O.
    Dtsch Med Wochenschr; 1985 Jan 04; 110(1):8-14. PubMed ID: 3880700
    [Abstract] [Full Text] [Related]

  • 35. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma.
    Drosos AA, Pennec YL, Elisaf M, Lamour A, Acritidis NC, Jouquan JR, Moutsopoulos HM, Youinou P.
    J Rheumatol; 1991 Nov 04; 18(11):1685-8. PubMed ID: 1787489
    [Abstract] [Full Text] [Related]

  • 36. Hydroxyapatite rheumatism and HLA markers.
    Amor B, Cherot A, Delbarre F, Nunez Roldan A, Hors J.
    J Rheumatol Suppl; 1977 Nov 04; 3():101-4. PubMed ID: 266590
    [Abstract] [Full Text] [Related]

  • 37. Specific lack of responsiveness to certain HLA-D (MLC) determinants with notes on primed lymphocyte typing (PLT).
    Thomsen M, Morling N, Platz P, Ryder LP, Staub-Nielsen L, Svejgaard A.
    Transplant Proc; 1976 Sep 04; 8(3):455-9. PubMed ID: 62436
    [No Abstract] [Full Text] [Related]

  • 38. Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases.
    Powell FC, Schroeter AL, Dickson ER.
    Q J Med; 1987 Jan 04; 62(237):75-82. PubMed ID: 3423208
    [Abstract] [Full Text] [Related]

  • 39. Expression of HLA class II antigens on skin fibroblasts in scleroderma.
    Branchet MC, Boisnic S, Blétry O, Robert L, Charron D, Francès C.
    Br J Dermatol; 1992 May 04; 126(5):431-5. PubMed ID: 1610682
    [Abstract] [Full Text] [Related]

  • 40. [Histocompatibility antigens (HL-A) in psoriasis. A study of 104 unrelated patients (author's transl)].
    Schoefinius HH, Braun-Falco O, Scholz S, Steinbauer-Rosenthal I, Wank R, Albert ED.
    Dtsch Med Wochenschr; 1974 Mar 08; 99(10):440-4. PubMed ID: 4471830
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.